These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25917767)

  • 1. Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.
    Ohls RK; Christensen RD; Widness JA; Juul SE
    J Pediatr; 2015 Jul; 167(1):10-2. PubMed ID: 25917767
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.
    Fauchère JC; Koller BM; Tschopp A; Dame C; Ruegger C; Bucher HU;
    J Pediatr; 2015 Jul; 167(1):52-7.e1-3. PubMed ID: 25863661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand.
    Garg B; Sharma D; Bansal A
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3214-3224. PubMed ID: 28797191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report.
    Luciano R; Fracchiolla A; Ricci D; Cota F; D'Andrea V; Gallini F; Papacci P; Mercuri E; Romagnoli C
    Ital J Pediatr; 2015 Sep; 41():64. PubMed ID: 26376632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awaiting evidence of neuroprotective effects of recombinant erythropoietin in very preterm infants.
    Dame C
    J Perinatol; 2013 May; 33(5):411. PubMed ID: 23624973
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroprotection with erythropoietin in preterm and/or low birth weight infants.
    Zhang J; Wang Q; Xiang H; Xin Y; Chang M; Lu H
    J Clin Neurosci; 2014 Aug; 21(8):1283-7. PubMed ID: 24650681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Fauchère JC;
    JAMA; 2020 Dec; 324(22):2324-2327. PubMed ID: 33289818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective role of erythropoietin in neonates.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():105-7. PubMed ID: 22958035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates.
    Messier AM; Ohls RK
    Curr Opin Pediatr; 2014 Apr; 26(2):139-45. PubMed ID: 24535496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perinatal neuroprotection in 2015].
    Bednarek N; Loron G; Venot P
    Arch Pediatr; 2015 Oct; 22(10):1005-7. PubMed ID: 26382640
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on Erythropoiesis-Stimulating Agents Administered to Neonates for Neuroprotection.
    Maxwell JR; Ohls RK
    Neoreviews; 2019 Nov; 20(11):e622-e635. PubMed ID: 31676737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoiesis-stimulating protein delivery in providing erythropoiesis and neuroprotection.
    Chang ZY; Chiang CH; Lu DW; Yeh MK
    Expert Opin Drug Deliv; 2008 Dec; 5(12):1313-21. PubMed ID: 19040394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to dr C dame.
    McAdams RM; McPherson RJ; Juul SE
    J Perinatol; 2013 May; 33(5):412. PubMed ID: 23624974
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates.
    Dame C; Langer J; Koller BM; Fauchère JC; Bucher HU
    Neonatology; 2012; 102(3):172-7. PubMed ID: 22776958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age.
    Leuchter RH; Gui L; Poncet A; Hagmann C; Lodygensky GA; Martin E; Koller B; Darqué A; Bucher HU; Hüppi PS
    JAMA; 2014 Aug; 312(8):817-24. PubMed ID: 25157725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of erythropoietin.
    Gu YL; Zhao ZX
    J Neurosurg; 2014 Jan; 120(1):293-4. PubMed ID: 24180572
    [No Abstract]   [Full Text] [Related]  

  • 18. Can erythropoietin improve developmental outcomes for preterm infants?
    McPherson RJ
    Pediatrics; 2009 Oct; 124(4):e805-6. PubMed ID: 19770176
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroprotective effects of erythropoietin in focal brain ischemia in rats.
    Prosvirnina MS; Shmonin AA; Mel'nikova EV; Vlasov TD
    Bull Exp Biol Med; 2014 Mar; 156(5):642-4. PubMed ID: 24770748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin, given enterally, stimulates erythropoiesis in premature infants.
    Ballin A; Bilker-Reich A; Arbel E; Davidovitz Y; Kohelet D
    Lancet; 1999 May; 353(9167):1849. PubMed ID: 10359412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.